AVROBIO Inc banner

AVROBIO Inc
NASDAQ:TECX

Watchlist Manager
AVROBIO Inc Logo
AVROBIO Inc
NASDAQ:TECX
Watchlist
Price: 30.52 USD -0.84% Market Closed
Market Cap: $573.2m

Profitability Summary

AVROBIO Inc's profitability score is 20/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

20 / 100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

20 / 100
Profitability
Score
20 / 100
Profitability
Score

Margins

Earnings Waterfall
AVROBIO Inc

Margins Comparison
AVROBIO Inc Competitors

Country Company Market Cap Operating
Margin
Net
Margin
US
AVROBIO Inc
NASDAQ:TECX
571.9m USD
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
369.2B USD
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
187.5B USD
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
173.4B USD
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
111.4B USD
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.5B USD
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
67B AUD
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
39.6B EUR
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...

Return on Capital

Return on Capital Comparison
AVROBIO Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
AVROBIO Inc
NASDAQ:TECX
571.9m USD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
369.2B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
187.5B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
173.4B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
111.4B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.5B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
67B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
39.6B EUR
Loading...
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
AVROBIO Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett